|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2008-9-17
|
|
pubmed:abstractText |
While clinical relapses are the defining feature of relapsing-remitting multiple sclerosis (RRMS), their characteristics vary widely from patient to patient. This study sought to identify predictors of MS relapse location. Based on the current literature, two potential predictors were identified: treatment with interferon beta (IFNB) and location of previous relapse.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1468-330X
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
79
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1190-3
|
|
pubmed:meshHeading |
pubmed-meshheading:18223021-Adjuvants, Immunologic,
pubmed-meshheading:18223021-Adult,
pubmed-meshheading:18223021-Brain Stem,
pubmed-meshheading:18223021-Cerebellum,
pubmed-meshheading:18223021-Cerebrum,
pubmed-meshheading:18223021-Female,
pubmed-meshheading:18223021-Humans,
pubmed-meshheading:18223021-Immunologic Factors,
pubmed-meshheading:18223021-Interferon-beta,
pubmed-meshheading:18223021-Magnetic Resonance Imaging,
pubmed-meshheading:18223021-Male,
pubmed-meshheading:18223021-Multiple Sclerosis,
pubmed-meshheading:18223021-Optic Nerve,
pubmed-meshheading:18223021-Peptides,
pubmed-meshheading:18223021-Prospective Studies,
pubmed-meshheading:18223021-Recurrence,
pubmed-meshheading:18223021-Retrospective Studies,
pubmed-meshheading:18223021-Spinal Cord
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Predictors of the location of multiple sclerosis relapse.
|
|
pubmed:affiliation |
Multiple Sclerosis Center, University of California at San Francisco, San Francisco, California 94117, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|
